17,242
21,718
30,962
31,488
34,222
37,642
Solis Case Study
Hospital “A”
2007
2008
2009
2010
2011
2012
Solis Case Study Hospital “B”
3,668
4,858
6,628
7,830
9,344
Average Percent Change
24%
39%
1% CMS Growth Rate
2008
2009
2010
2011
2012
* First Year Under Solis Management.
Solis Manages Procedure Volume Growth
2007-2008 2008-2009 2009-2010 2010-2011 2011-2012 Average
26% 43% 2% 9% 10% 24%Solis Case Study Hospital “A” *
32% 36% 18% 19% 39%Solis Case Study Hospital “B” *
1% 1% 1% 1% 1% 1%CMS Annual Industry Growth Rate
Begin a Partnership with Solis Mammography.
Contact us for more information
Reese Walter Chief Development Ofcer
919.349.1881 |
[email protected]
The information contained in this document is provided on an “as is” basis without any warranties, and may not be relied upon for future results. Solis does not guarantee
any financial or other performance results, which are subject to a number of uncontrollable conditions such as the market. This document is confidential and may not be
used for the personal benefit of any person or entity outside of Solis, without the prior written consent of Solis. © Solis Mammography. All rights reserved.
Rev: 10/2014 6
Advantages for Hospitals from a Joint Venture Partnership
Because women are usually the primary healthcare decision makers for their families. A great
reoccurring annual mammography experience can translate into additional family members and
friends becoming patients in other service areas of a hospital. Hospital partners of Solis receive the
following:
• The expertise of Solis to deliver world class breast screening and diagnosis delivered
to hospital campus.
• Optimized downstream surgery and oncology revenue from diagnosed breast cancers.
• Improved financial performance of mammography through volume growth.
• Enhanced patent care, patient satisfaction and patient loyalty.
• Opportunities for improved quality and experience of care in breast imaging.
• An opportunity for risk based contracting (ACO) of mammography.
• Capitalizes the revenue growth of Solis and expands EBITDA margin by using the hospital’s tax ID
(favorable HOPD reimbursement rates).
In 2013, Solis
diagnosed
1,682 cancers.